1. Summary of reported outcome measures.

Study ID	Patient survival	Graft survival	Acute rejection	CNI toxicity	Adverse effects	Compliance	Kidney function	Blood pressure	Lipid profile
Bennett (high) 1995; Bennett (low) 1995	X	X	X	‐	‐	‐	X	‐	X
Berthoux 1992	X	X	‐	‐	‐	‐	X	X	X
Busnach 1998	X	X	X	‐	‐	X	X	X	X
Castro 1997	‐	‐	‐	‐	‐	‐	‐	‐	X
Hernandez 2002	X	X	X	X	X	X	X	X	X
Homan van der Heide 1990a	X	X	X	‐	X	‐	X	X	‐
Homan van der Heide 1990b	X	X	X	‐	‐	X	X	X	‐
Homan van der Heide 1992	X	X	X	‐	‐	X	X	X	‐
Homan van der Heide 1993	X	X	X		X	X	X	X	‐
Kooijmans‐Coutinho 1996	X	X	X	‐	X	X	X	X	‐
Maachi 1995	X	X	X	‐	X	X	X	‐	X
Rodriguez 1997	‐	‐	‐	‐	‐	‐	‐	‐	X
Santos 2000	X	X	X	‐	X	X	X	X	X
Schut 1992a; Schut 1992b	‐	‐	‐	‐	‐	‐	X	X	‐
Yoa 1994	‐	‐	‐	‐	‐	‐	X	‐	X

CNI ‐ calcineurin inhibitor